1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 25
2.1.3 Impact of Russia-Ukraine Conflict 27
2.1.4 Impact of Israel-Palestine War 29
2.2 Major Growth Drivers 30
2.3 Market Restraints and Challenges 35
2.4 Emerging Opportunities and Market Trends 38
2.5 Porter's Fiver Forces Analysis 41
3 Segmentation of Global Market by Offering 45
3.1 Market Overview by Offering 45
3.2 Drugs 48
3.2.1 Opioids 50
3.2.2 NSAIDS 51
3.2.3 Anesthetics 52
3.2.4 Anticonvulsants 53
3.2.5 Anti-depressants 54
3.2.6 Non-narcotic Analgesics 55
3.3 Devices 56
3.3.1 Neurostimulation Devices 57
3.3.2 Analgesic Infusion Pumps 58
4 Segmentation of Global Market by Application 59
4.1 Market Overview by Application 59
4.2 Neuropathic Pain 62
4.3 Cancer Pain 63
4.4 Facial Pain and Migraine 64
4.5 Musculoskeletal Pain 65
4.6 Post-operative Pain 66
4.7 Chronic Back Pain 67
4.8 Arthritic Pain 68
4.9 Other Applications 69
5 Segmentation of Global Market by Distribution Channel 70
5.1 Market Overview by Distribution Channel 70
5.2 Hospitals Pharmacy 73
5.3 Online Pharmacy 74
5.4 Retail Pharmacy 75
6 Segmentation of Global Market by Region 76
6.1 Geographic Market Overview 2023-2033 76
6.2 North America Market 2023-2033 by Country 81
6.2.1 Overview of North America Market 81
6.2.2 U.S. 85
6.2.3 Canada 88
6.2.4 Mexico 90
6.3 European Market 2023-2033 by Country 92
6.3.1 Overview of European Market 92
6.3.2 Germany 96
6.3.3 U.K. 98
6.3.4 France 100
6.3.5 Spain 102
6.3.6 Italy 104
6.3.7 Russia 106
6.3.8 Rest of European Market 108
6.4 Asia-Pacific Market 2023-2033 by Country 110
6.4.1 Overview of Asia-Pacific Market 110
6.4.2 Japan 114
6.4.3 China 117
6.4.4 Australia 119
6.4.5 India 121
6.4.6 South Korea 123
6.4.7 Rest of APAC Region 125
6.5 South America Market 2023-2033 by Country 127
6.5.1 Argentina 131
6.5.2 Brazil 133
6.5.3 Chile 135
6.5.4 Rest of South America Market 137
6.6 MEA Market 2023-2033 by Country 138
6.6.1 UAE 142
6.6.2 Saudi Arabia 144
6.6.3 South Africa 146
6.6.4 Other National Markets 148
7 Competitive Landscape 149
7.1 Overview of Key Vendors 149
7.2 New Product Launch, Partnership, Investment, and M&A 152
7.3 Company Profiles 153
Abbott Laboratories Inc. 153
Baxter International Inc. 155
Becton, Dickinson and Company 156
Boehringer Ingelheim International GmbH 157
Boston Scientific Corporation 158
Eli Lilly & Company 159
Endo Health Solutions, Inc. 160
Fresenius SE & Co. KGaA 161
GlaxoSmithKline PLC 162
Johnson & Johnson 163
Medtronic PLC 164
Merck & Co. Inc. 165
Novartis AG 166
Pfizer Inc. 167
Purdue Pharma L.P 168
Teva Pharmaceutical Industries Ltd. 169
8 Investing in Pain Management Industry: Risk Assessment and Management 170
8.1 Risk Evaluation of Global Market 170
8.2 Critical Success Factors (CSFs) 176
RELATED REPORTS 179
?